Reinventing precision medicine: from dogs to humans
January 26, 2023
Speaker: Sungwon Lim, PhD, CEO & Co-Founder of ImpriMed, Inc.
Date: January 26, 20223
Description: ImpriMed provides an anticancer drug efficacy prediction service using artificial intelligence on a patient's live cancer cell data, aiming to help oncologists personalize a treatment regimen tailored to each patient's unique cancer in both human and veterinary oncology. ImpriMed's comparative oncology platform enables new precision medicine services for both human and animal cancers.